Loading...
Key Product Details
- R&D Systems NS0-derived Recombinant Human PAM Protein (4837-AM)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
NS0
Accession Number
Applications
Enzyme Activity
Loading...
Product Specifications
Source
Mouse myeloma cell line, NS0-derived human PAM protein
Met1-Val817, with a C-terminal 10-His tag
Met1-Val817, with a C-terminal 10-His tag
Purity
>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Phe21
Predicted Molecular Mass
90 kDa
SDS-PAGE
79-92 kDa, reducing conditions
Activity
Measured by its ability to convert Hippurate to Benzamide and Glyoxylate.
The specific activity is >1000 pmol/min/μg, as measured under the described conditions.
The specific activity is >1000 pmol/min/μg, as measured under the described conditions.
Formulation, Preparation, and Storage
4837-AM
| Formulation | Supplied as a 0.2 μm filtered solution in Tris and NaCl. |
| Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: PAM
References
- Kizer J.S. et al. (1986) Endocrinol. 118:2262.
- Perkins S.N. et al. (1990) Biochem. Biophys. Res. Commun. 171:926.
- Eipper B.A. et al. (1993) Protein Sci. 2:489.
Long Name
Peptidylglycine Alpha-Amidating Monooxygenase
Alternate Names
PAL, PHM
Gene Symbol
PAM
UniProt
Additional PAM Products
Product Documents for Recombinant Human PAM Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant Human PAM Protein, CF
For research use only
Related Research Areas
Customer Reviews for Recombinant Human PAM Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human PAM Protein, CF and earn rewards!
Have you used Recombinant Human PAM Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
View specific protocols for Recombinant Human PAM Protein, CF (4837-AM):
Materials
- Assay Buffer: 50 mM MES, pH 6.0
- Recombinant Human Peptidylglycine alpha ‑Amidating Monooxygenase/PAM (rhPAM) (Catalog # 4837-AM)
- Substrate: Sodium Hippurate [0.5 M Hippuric Acid (Sigma, Catalog # 112003) in 0.5 M NaOH]
- Standard: Sodium Glyoxylate
- Glyoxylate Development Solution
- Catalase (Sigma, Catalog # C30), 100,000 units/mL stock in 50 mM MES, pH 6.5
- L-Ascorbic Acid (Sigma, Catalog # 255564), 0.5 M stock in deionized water
- Copper (II) Chloride (Sigma, Catalog # 222011), 1 M stock in deionized water
- F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
- Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
- Dilute the standard to 2000 μM in Assay Buffer. Prepare the standard curve by performing six ½ serial dilutions of the 2000 μM standard. The standard curve has a range of 0.625 to 40 nmol per well.
- Dilute rhPAM to 5 ug/mL in cold Assay Buffer. Keep on ice.
- Dilute Substrate to 20 mM in Assay Buffer.
- Prepare a Reaction Mixture containing 4000 Units/mL of Catalase, 0.2 μM of Copper Chloride and 10 mM of Ascorbic Acid in cold Assay Buffer. Keep on ice. (Note: Dilute Copper Chloride to 10 μM in deionized water before adding to the mixture to prevent precipitation.)
- In microtubes, combine 75 μL of rhPAM with 150 μL of Reaction Mixture. As a Substrate Blank, combine 75 μL of Assay Buffer with 150 μL of Reaction Mixture. For the standard curve, combine 75 μL of each dilution of the standard curve with 150 μL of Reaction Mixture.
- Start the reaction by adding 75 μL of 20 mM Substrate to all vials.
- Incubate at 37 °C for 1 hour.
- Add 300 μL of Glyoxylate Development Solution to each vial, mix briefly and incubate at 95‑100 °C for exactly 2 minutes.
- Cool the vials on ice for 3 minutes.
- Into the plate, pipette 160 μL of Substrate Blank, each dilution of the standard curve, and reactions to empty wells in triplicate.
- Read plate in endpoint mode at excitation and emission wavelengths of 330 nm and 415 nm (top read), respectively.
- Calculate specific activity:
|
Specific Activity (pmol/min/µg) = |
Glyoxylate produced* (nmol) x (1000 pmol/nmol) |
| Incubation time (min) x amount of enzyme (µg) |
*Derived from a sodium glyoxylate standard curve using linear fitting and adjusted for Substrate Blank.
Per Reaction:- rhPAM: 0.1 μg
- Standard Curve: 0.625, 1.25, 2.5, 5, 10, 20, 40 nmol
Loading...